Boston Scientific Corporation
$65.03
▲
9.26%
2026-04-22 10:12:13
www.bostonscientific.com
NYQ: BSX
Explore Boston Scientific Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$96.13 B
Current Price
$65.03
52W High / Low
$109.5 / $60.59
Stock P/E
33.52
Book Value
$16.34
Dividend Yield
0%
ROCE
10.39%
ROE
12.45%
Face Value
—
EPS
$1.94
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
59,000
Beta
0.78
Debt / Equity
48.92
Current Ratio
1.62
Quick Ratio
1.08
Forward P/E
15.84
Price / Sales
4.57
Enterprise Value
$101.94 B
EV / EBITDA
19.09
EV / Revenue
5.08
Rating
Strong Buy
Target Price
$98.72
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | DexCom, Inc. | $63.4 | 30.77 | $24.57 B | — | 21.72% | 34.5% | $89.98 / $54.11 | $7.14 |
| 2. | Enovis Corporation | $26.27 | — | $1.52 B | — | -0.58% | -58.27% | $37.85 / $21 | $26.05 |
| 3. | PAVmed Inc. | $9.44 | 150.27 | $60.26 M | — | -89.22% | -32.34% | $28.44 / $6 | $10.01 |
| 4. | Artivion, Inc. | $38.8 | 193.48 | $1.89 B | — | 3.41% | 2.7% | $48.25 / $22.22 | $9.37 |
| 5. | Standard BioTools Inc. | $0.97 | — | $361.83 M | — | -20.31% | -13.13% | $1.72 / $0.87 | $1.23 |
| 6. | STERIS plc | $223.73 | 31.17 | $21.95 B | 1.11% | 10.53% | 10.47% | $269.44 / $209.98 | $72.93 |
| 7. | Inspire Medical Systems, Inc. | $56.97 | 11.28 | $1.64 B | — | 6.28% | 19.77% | $163.35 / $48.3 | $27.33 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 5.29 B | 5.07 B | 5.06 B | 4.66 B | 4.56 B | — |
| Operating Profit | 1.04 B | 1.05 B | 943 M | 937 M | 790 M | — |
| Net Profit | 672 M | 755 M | 797 M | 674 M | 566 M | — |
| EPS in Rs | 0.45 | 0.51 | 0.54 | 0.45 | 0.38 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 20.07 B | 16.75 B | 14.24 B | 12.68 B |
| Operating Profit | 3.97 B | 3 B | 2.42 B | 2.03 B |
| Net Profit | 2.9 B | 1.85 B | 1.59 B | 698 M |
| EPS in Rs | 1.95 | 1.25 | 1.07 | 0.47 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 43.67 B | 39.4 B | 35.14 B | 32.47 B |
| Total Liabilities | 19.2 B | 17.39 B | 15.61 B | 14.9 B |
| Equity | 24.23 B | 21.77 B | 19.28 B | 17.57 B |
| Current Assets | 8.79 B | 6.92 B | 6.51 B | 5.76 B |
| Current Liabilities | 5.44 B | 6.4 B | 4.93 B | 3.8 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 4.53 B | 3.44 B | 2.5 B | 1.53 B |
| Investing CF | -2.64 B | -5.69 B | -2.57 B | -2.01 B |
| Financing CF | -395 M | 1.81 B | 5 M | -548 M |
| Free CF | 3.4 B | 2.37 B | 1.7 B | 914 M |
| Capex | -1.13 B | -1.07 B | -800 M | -612 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 17.61% | 12.29% | — | — |
| Earnings Growth % | 16.38% | 128.22% | — | — |
| Profit Margin % | 11.07% | 11.19% | 5.5% | — |
| Operating Margin % | 17.93% | 16.97% | 16.04% | — |
| Gross Margin % | 68.61% | 69.49% | 68.81% | — |
| EBITDA Margin % | 23.03% | 24.2% | 21.66% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.